Levetiracetam Basic information | |
Product Name: | Levetiracetam |
Synonyms: | (S)-2-(2-Oxo-1-pyrrolidinyl)butanamide;levetiracetamrawmateri;(2S)-2-(2-Oxopyrrolidin-1-yl)butanamide;(2S)-(2-Oxopyrrolidin-1-yl)butyramide;1-Pyrrolidineacetamide,.alpha.-ethyl-2-oxo-,(.alpha.S)-;Levetiracetam(200mg);(2R)-2-(2-oxopyrrolidin-1-yl)butanaMide;(αS)-α-Ethyl-2-oxo- |
CAS: | 102767-28-2 |
MF: | C8H14N2O2 |
MW: | 170.20896 |
EINECS: | 600-348-9 |
Product Categories: | Drugs; Central nervous system medication; Central stimulant drugs (including metabolic activators of brain function); Small molecule inhibitor; Nervous system medicine; Pharmaceutical raw materials; Organic raw materials; Biochemical reagents; Antiepileptic class; Nervous system medicine; Pharmaceutical intermediate; Active pharmaceutical ingredients. Intermediates; Levetiracetam; Reference – impurity reference; Medical raw materials; Apis, intermediates; Chemical intermediates; Scientific reagent; Pharmaceutical, pesticide and dye intermediates; Chemical reagent |
Introduction | Levetiracetam (LEV), a derivative of piracetam, is a new antiepileptic drug. |
Application | It is suitable for the adjunctive treatment of partial or secondary generalized seizures in adult epilepsy patients.
Antiepileptic drugs. (S) -enantiomer of this product etiracetam and ethyl analogue of piracetam. Used as an anticonvulsant, neuroprotective and neurological research product. |
Levetiracetam Chemical Properties | |
Melting point | 118-119°C |
flash point | 9℃ |
specific rotation | -89.7 º |
Storage condition | 2-8°C |
Solubility | H2O: >5mg/mL |
form | Powder. |
color | White |
optical activity | [α]/D -90±5°, c = 1 in acetone |